The efficacy of adenovirus-mediated gene therapy of ovarian cancer is enhanced by using the cytomegalovirus promoter Article

Tong, XW, Engehausen, DG, Freund, CTF et al. (1998). The efficacy of adenovirus-mediated gene therapy of ovarian cancer is enhanced by using the cytomegalovirus promoter . ANTICANCER RESEARCH, 18(2A), 719-725.

cited authors

  • Tong, XW; Engehausen, DG; Freund, CTF; Agoulnik, I; Guo, ZS; Oehler, MK; Kim, TE; Hasenburg, A; Contant, CF; Woo, SLC; Kieback, DG

sustainable development goals

authors

publication date

  • March 1, 1998

webpage

published in

keywords

  • CARCINOMA
  • CELL-GROWTH
  • CMV promoter
  • COLORIMETRIC ASSAY
  • EXPRESSION
  • GANCICLOVIR
  • IN-VIVO
  • Life Sciences & Biomedicine
  • MOUSE MODEL
  • Oncology
  • REGRESSION
  • RSV promoter
  • Science & Technology
  • THYMIDINE KINASE GENE
  • TRANSDUCTION
  • cell killing efficacy
  • gene therapy
  • ovarian cancer

publisher

  • INT INST ANTICANCER RESEARCH

start page

  • 719

end page

  • 725

volume

  • 18

issue

  • 2A